DASATINIB, Dasatinib, dasatinib, dasatinib clinical trials

A Phase II Study of Dasatinib Therapy in Children and Adolescents with Ph+ Leukemias Resistant or Intolerant to Imatinib.

This study is for children and teenagers with a type of blood cancer called Ph+ leukemia. It looks at how well a medicine called Dasatinib works if their current treatment, Imatinib, isn't working effectively or if they can't take it.